Nephrotic syndrome refers to a clinical condition characterized by heavy proteinuria, hypoalbuminemia, edema, and hyperlipidemia. It is most commonly caused by minimal change disease in children and membranous nephropathy in adults. The pathogenesis involves structural or functional alterations of the glomerular basement membrane, leading to increased permeability and loss of plasma proteins in the urine. Long-term nephrotic syndrome can result in complications like hypercoagulability, lipid abnormalities, and progressive kidney damage.
Inroduction
Nephrotic syndrome is one of the bcommon cause of hospitalization among children.
Incidence of the condition is 2 to7 per1000.
It is more common in male child.
Mean age of occurrence is 2 to 5 years.
It is a symptom complex manifested by massive oedema, hypoalbuminemia, marked albuminuria and hyperlipidemia
Classification
Congenital nephrotic syndrome
Idiopathic or primary nephrotic syndrome
Secondary nephrotic syndrome
Congenital nephrotic syndrome
It is rare but serious and fatal problem usually associated with other congenital abnormalities of kidney.
It is inherited as autosomal recessive disease.
Severe renal insufficiency and urinary infections along with this condition result is poor prognosis.
Idiopathic or primary nephrotic syndrome
It is the most common type(about 90%) and regarded as autoimmune phenomenon as it responds to immunosuppressive therapy.
Subgroup of this type◦ Minimal change nephrotic syndrome(85%)◦ Proliferative nephrotic syndrome(5%)◦ Focal sclerosis nephrotic syndrome(10%)
https://youtu.be/2Y8JNkiU29s This is the link for video lecture for the same topic. It is available in easy and comfortable language.
The Nephrotic Syndrome is a clinical state characterized by-
Proteinuria
Hypoalbuminemia
Hyperlipidemia and
Oedema.
It is a primary glomerular disease.
Steroid resistant nephrotic syndrome in children: Clinical presentation, rena...iosrphr_editor
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
Inroduction
Nephrotic syndrome is one of the bcommon cause of hospitalization among children.
Incidence of the condition is 2 to7 per1000.
It is more common in male child.
Mean age of occurrence is 2 to 5 years.
It is a symptom complex manifested by massive oedema, hypoalbuminemia, marked albuminuria and hyperlipidemia
Classification
Congenital nephrotic syndrome
Idiopathic or primary nephrotic syndrome
Secondary nephrotic syndrome
Congenital nephrotic syndrome
It is rare but serious and fatal problem usually associated with other congenital abnormalities of kidney.
It is inherited as autosomal recessive disease.
Severe renal insufficiency and urinary infections along with this condition result is poor prognosis.
Idiopathic or primary nephrotic syndrome
It is the most common type(about 90%) and regarded as autoimmune phenomenon as it responds to immunosuppressive therapy.
Subgroup of this type◦ Minimal change nephrotic syndrome(85%)◦ Proliferative nephrotic syndrome(5%)◦ Focal sclerosis nephrotic syndrome(10%)
https://youtu.be/2Y8JNkiU29s This is the link for video lecture for the same topic. It is available in easy and comfortable language.
The Nephrotic Syndrome is a clinical state characterized by-
Proteinuria
Hypoalbuminemia
Hyperlipidemia and
Oedema.
It is a primary glomerular disease.
Steroid resistant nephrotic syndrome in children: Clinical presentation, rena...iosrphr_editor
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
Nephrotic syndrome happens when damage to your kidneys causes these organs to release too much protein into your urine.
Nephrotic syndrome isn’t itself a disease. Diseases that damage blood vessels in your kidneys cause this syndrome.
Nephrotic syndrome is characterized by the following:
A high amount of protein present in the urine (proteinuria)
high cholesterol and triglyceride levels in the blood (hyperlipidemia)
Low levels of a protein called albumin in the blood (hypoalbuminemia)
Swelling (edema), particularly in your ankles and feet, and around your eyes.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
4. Nephrotic syndrome refers to a clinical complex that
includes
• Massive proteinuria with daily protein loss in the
urine of > 3.5 g or more in adults.
• hypoalbuminemia, with plasma albumin level less
than 3 g/dl
• Generelised edema most obvious clinical
manifistation
• hyperlipidemia, and lipiduria
NEPHROTIC SYNDROME
5. • 2 – 7 cases per 100,000 per year
• Higher in underdeveloped countries (South east
Asia)
• Occurs at all ages but is most prevalent in
children between the ages 1.5-6 years.
• It affects more boys than girls, 2:1 ratio
Incidence
8. All causes of nephrotic syndrome share a common
pathophysiology.
Structural or physiochemical alteration in GBM
Derangement in capillary wall of glomeruli
Increased permeability to plasma proteins.
escape from plasma into glomerular filtrate.
pathophysiology
9. longstanding heavy proteinuria serum
serum albumin is decreased , resulting in hypoalbumenia
decrease in intravascular volume and decreased renal blood flow.
release of renin by JG cells
stimulates angiotension – aldosterone axis which promote retention of salt
and water by kidney.
odema
Cont..
10. • Effacement of
podocytes is now
thought to be the
primary pathology.
• -ve charge of the
basement membrane is
also important
stuctural vs physiochemical alteration.
11. • glomerular wall has two filtration barriers in
series;
inner :-charge dependent membrane;
more external, mainly size selective barrier
So Glomerular filter acts via two phenomenon
size selectivity
charge selectivity
Selectivity of proteinuria
12. • Excretion of relatively low M.W. protein
(Albumin or transferrin) is known as selective
proteinuria while
• if excretion is predominately high M.W. protein
(IgG, IgM or α2 macroglobulin) it is nonselective
proteinuria.
• It is also related to relative damage of
Glomerular filter.
Selectivity of proteinuria
13. • It is due to both the proteinuria and due to the
increase renal catabolism (in tubules).
• Infact hepatic albumin synthesis is increased
from 145±9mg/kg/day to 213±17mg/kg/day in
nephrotic patients.
• Transcriptiional regulation of human albumin
synthesis is not co-related with plasma oncotic
pressure or albumin concentration, but rather
with urinary albumin execration.
HYPOALBUMINEMIA
14. • As abnormal accumulation of interstitial fluid
and becomes obvious if in excess of 10% of B.W.
• Usually present as edema around
eyes
ankle
sacral pad
elbows
ascitis
pleural effusion.
EDEMA
15. hypoalbuminemia → decrease intravascular oncotic
pressure
↓
leakage of fluid from blood to interstitium
↓
↓ intravascular volume
↓
activates sympathetic N.S. and RAS and promote
vasopressin secretion & suppressing ANP release
↓
increase salt and water retension
↓
restore intravascular volume
↓
further leakage of fluid to interstitum.
Pathogenesis of Edema : underfill hypothesis :
16. • occurrence edema in many patients whom plasma
volume is expended
• RAA axis is suppressed
• High BP argues against hypovolemia and infact,
suggest hypervolemia.
This hyopthesis fail to explain ….
17. intrinsic defect of salt and water excretion in the
nephrotic kidney.
Activation of the expression of Na+/H+exchanger3
(NHE3)
Stimulation of the basolateral Na,K-ATPase pump
Activation of the apical epithelial amiloride-
sensitive sodium channels (ENa+C))
primary renal salt and water retention
theory/ The “overfill” theory
18.
19.
20.
21. • Presumed that hypoalbuminemia triggers the
increased synthesis of lipoproteins in liver.
• massive proteinuria causes loss of inhibitor of their
synthesis
• There is abnormal transport of circulating lipid
particles.
• Defective lipid catabolism has also important role.
• lipiduria – increased permiability of GBM to
lipoproteins
Hyperlipidemia & lipiduria
22. LDL and cholesterol are increased in majority of
patients whereas
VLDL and triglyceride tends to rise in patients with
severe disease.
Risk due to hyperlipidemia
relative risk for MI 5.5 fold ,
coronary death 2.8 fold.
It also increases progression of renal disease
CONT.
23. Increase urinary loss of antithrombin III.
Altered levels and/or activity of protein C & S.
Hyperfibronogenemia due to increase
hepatic synthesis.
Impaired fibrinolysis due to decrease
plasminogen.
HYPERCOAGULABILITY
24. Patients may develop peripheral arterial or venous
thrombosis,
renal vein thrombosis and pulmonary embolism.
Renal vein thrombosis (men >women) is very important
and common (up to 40% adults patients).
- Renal thrombosis usually associated with membranous
nephropathy, MPGN and amyloidosis.
Risk due to hypercoagulibity
25. • Also called as lipoid nephrosis or foot process
disease.
• Relatively benign disorder.
• most frequent cause of nephrotic syndrome in children
( 20% adults .80 % children).
• Hypertension and renal failure are very rare.
MINIMAL CHANGE DISEASE
26. • Idiopathic (majority)
• In association with ;
- Drug -NSAIDs, rifampin, interferon alpha.
- Systemic diseses -Hodgkin’s disease and other
lympho-proliferative malignancy.
- HIV infection.
MAJOR CAUSES OF MCD
27. • exact pathology is not known
• experimental studies - Proteinuria d/t circulating T
cell derived factor that cause podocyte damage
and effacement of foot proceesses.
• neither nature nor role in human study establshed
• Detection of a mutation in nephrin gene in
cases of congenital MCD has focused attention on
genetic basis.
Pathogenesis ..
28. • Primary FSGS comprises about 1/3 rd cases of NS
in adults.
Causes –
• Idiopathic ( majority)
• Secondary FSGS
-HIV nephropathy
-Heroin Nephropathy.
-Maladaptation to Nephron loss
-Secondary event in IgA nephropathy.
FOCAL SEGMENTAL
GLOMERULOSCLEROSIS
29. pathogenesis of primary FSGS unknown.
some suggest that MCD may transform into FSGS.
Injury to podocyte is thought to represent the
initiating event of primary FSGS.
as with MCD permeability increasing factors
produced by lymphocytes are also proposed.
deposition of hyaline masses in glomeruli
represents the plasma proteins and lipids where
sclerosis develops.
Pathogenesis …FSGS
30. • Leading cause of idiopathic nephrotic syndrome in
adults (30 to 40%) with male to female ratio
of 2 :1.
Age group 30 – 60 yrs
it is characterized morphologically by presence of
sub-epithelial immunoglobulin containing deposits.
MEMBRANOUS NEPHROPATHY
32. • its is form of chronic immune complex
glomerulonephritis induced by antibodies reacting
in situ to endogenous or planted glomerural antigen.
• An endogenous podocyte antigen , phospholipid A 2
receptor is most often recognized by autoantibodies.
• Antigen antibody complexes causes capillary damage
by activation of complements ( c5b-c9 MAC0 without
inflamation ,
Pathogenesis
33.
34. • 5-10 % cases of idiopathic nephrotic syndrome in
children and adults.
• some patients presents only hemaruria or
protenuria of non nephrotic range other exbits
combined nephrotic nephritic picture.
• MPGN type 1 – circulating immune complexes.
• Dense deposit disease- excessive complement
activation by c3 nephritic factor.
• principal mode presentation is nephrotic syndrome.
MEMBRANOPROLIFERATIVE
GLOMERULONEPHRITIS
35. Most imp. Predictor - duration of disease.
20 years prediction of nephropathy is
Type I DM have 30-40 %chances
Type II DM have 30-40 %chances
Risk factors
hyperglycemia,
systemic hypertension,
glomerular hypertension and' hyperfilteration, proteinuria,
cigarette smoking,
hyperlipidemia
DIABETIC NEPHROPATHY
36. • Hyperglycemia and insulin deficiency lead to
non enzymatic glycation of proteins in GBM.
• subsequent hemodynamic changes –
Increased GFR ,
Increased glomerular capillary pressure,
Glomerular hypertrophy,
Glomerulosclerosis.
• earliest finding – increased GFR .
Pathogenesis
37. • diagnosed on clinical grounds without a renal
biopsy.
• Supportive clues are
presence of normal sized or enlarged kidneys,
evidence, proliferative diabetic retinopathy,
and urinary sediments.
Retinopathy is found in 90 % - with type I DM
60% of patients type II DM
38. • Glomeruli are involved in 75 to 90% of patients.
• Hypertension is present in 20-25%.
• Renal size is usually normal or slightly enlarged.
• A minority of patients present with renal failure.
• Rectal biopsy and abdominal fat pad biopsy
reveal amyloid deposits in about 75% of patients
and may obviate the need for renal biopsy.
RENAL AMYLOIDOSIS
39. Finnish’ Type Nephrotic Syndrome
• Presents in first 3 months of life
c/f Anasarca, hypoalbuminaemia, oliguria
‘Antenatally detectable :
– Raised AFP in maternal serum and amniotic fluid
• Complications
– Failure o thrive
– Infections
– Hypothyroidism
– Renal Failure ( 2 – 3 yrs )
Congenital Nephrotic Syndrome
activation of the expression of Na+/H+exchanger3 (NHE3) in the apical membrane of the proximal tubules by the tubular albumin
•proteinuria-induced stimulation of the basolateral Na,K-ATPase pump in the collecting ducts (20-21-22)
•activation of the apical epithelial amiloride-sensitive sodium channels (ENa+C) in the collecting ducts induced by urine proteases (plasminogen/plasmin) (2, 23-24-25-26)
•tubular resistance to ANP (the result of an increased cyclic guanosine monophosphate (cGMP) phosphodiesterase activity and depletion of cGMP, which is the ANP second messeng